These included homozygous PTEN loss in 57% (4/7) SCNEC but not in any LCNEC or ANEC, and activating hotspot PIK3CA mutations in 3 tumors (1 SCNEC, 1 ANEC, 1 LCNEC). Here, PIK3CA is linked to large cell neuroendocrine carcinoma.